Quantcast
Last updated on April 19, 2014 at 5:20 EDT

Latest Alder Stories

2012-06-04 02:26:12

BOTHELL, Wash., June 4, 2012 /PRNewswire/ -- Alder Biopharmaceuticals Inc. today announced that the company is scheduled to present at the Jefferies Global Healthcare Conference at 11:30 a.m. EDT on Tuesday, June 5. Randall Schatzman, Ph.D., president and chief executive officer, will provide an overview of the company and an update about its clinical programs. "We look forward to this opportunity to provide an update about Alder as we move forward with clinical investigations of...

2012-02-24 07:00:00

BOTHELL, Wash., Feb. 24, 2012 /PRNewswire/ -- Alder Biopharmaceuticals Inc. today announced that Randall Schatzman, Ph.D., president and chief executive officer, will participate in a panel focused on antibody therapeutics during the RBC Capital Markets Global Healthcare Conference in New York City at 10 a.m. EST on Tuesday, February 28. "As a class antibody therapeutics have been highly successful, however there have been limitations to conventional technologies that have held the...

2010-11-01 11:11:00

BOTHELL, Wash., Nov. 1, 2010 /PRNewswire/ -- Alder Biopharmaceuticals Inc. today announced that it has appointed A. Bruce Montgomery, M.D., to the company's board of directors. Dr. Montgomery, 57, served as founder and chief executive officer of Corus Pharmaceuticals from 2001 through its acquisition in 2006 by Gilead Sciences. While at Gilead, he served as Senior Vice President and Head of Respiratory Therapeutics where he successfully led the approval of Cayston (aztreonam) as a...

2010-08-03 09:12:00

CLEVELAND, Aug. 3 /PRNewswire/ -- Herbruck Alder, a Cleveland-based employee benefits firm, will bring together executives from five medical insurance companies to update employers about the new federal healthcare reform law at a special forum on Thursday, August 12 at La Centre Conference Center in Westlake. Invited to the conference, which takes place from 8:30 a.m. to 1:30 p.m., are human resources executives, CFOs, Presidents, Owners and other institutional healthcare...